The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial.

Thriemer K, Commons RJ, Rajasekhar M, Degaga TS, Chand K, Chau NH, Assefa A, Naddim MN, Pasaribu AP, Rahim AG, Sutanto I, Hien TT, Hailu A, Hasanzai MA, Ekawati LL, Woyessa A, Teferi T, Waithira N, Taylor WRJ, Ley B, Dondorp A, Baird JK, White NJ, Day NP, Price RN, Simpson JA, von Seidlein L

Open source

DOI: 10.1186/s12874-023-02022-3
Published: 2023 Sep 4
Container: BMC medical research methodology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12874-023-02022-3,
  title = {The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial.},
  author = {Thriemer K and Commons RJ and Rajasekhar M and Degaga TS and Chand K and Chau NH and Assefa A and Naddim MN and Pasaribu AP and Rahim AG and Sutanto I and Hien TT and Hailu A and Hasanzai MA and Ekawati LL and Woyessa A and Teferi T and Waithira N and Taylor WRJ and Ley B and Dondorp A and Baird JK and White NJ and Day NP and Price RN and Simpson JA and von Seidlein L},
  year = {2023},
  journal = {BMC medical research methodology},
  doi = {10.1186/s12874-023-02022-3},
  url = {https://doi.org/10.1186/s12874-023-02022-3}
}

RIS

TY  - JOUR
TI  - The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial.
AU  - Thriemer K
AU  - Commons RJ
AU  - Rajasekhar M
AU  - Degaga TS
AU  - Chand K
AU  - Chau NH
AU  - Assefa A
AU  - Naddim MN
AU  - Pasaribu AP
AU  - Rahim AG
AU  - Sutanto I
AU  - Hien TT
AU  - Hailu A
AU  - Hasanzai MA
AU  - Ekawati LL
AU  - Woyessa A
AU  - Teferi T
AU  - Waithira N
AU  - Taylor WRJ
AU  - Ley B
AU  - Dondorp A
AU  - Baird JK
AU  - White NJ
AU  - Day NP
AU  - Price RN
AU  - Simpson JA
AU  - von Seidlein L
PY  - 2023
JO  - BMC medical research methodology
DO  - 10.1186/s12874-023-02022-3
UR  - https://doi.org/10.1186/s12874-023-02022-3
ER  -

APA

K, T., RJ, C., M, R., TS, D., K, C., NH, C., A, A., MN, N., AP, P., AG, R., I, S., TT, H., A, H., MA, H., LL, E., A, W., T, T., N, W., WRJ, T., B, L., A, D., JK, B., NJ, W., NP, D., RN, P., JA, S., & L, V. S. (2023). The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial.. BMC medical research methodology. https://doi.org/10.1186/s12874-023-02022-3

Source records

pubmed · retrieved 2026-09-25T21:24:56.182Z